Pathology/Biomarker

General pathologic evaluation of drug related toxicity in rodent

Effymed Path/BM team has experience for quick evaluation of drug related histopathology changes. We can provide service for sectioning, H&E staining and microscopic evaluation of pathologic changes to support non-GLP toxicity studies for drug development

IHC profiling and biomarker confirmation

Effymed has accumulated tremendous experience of IHC studies, particularly many biomarkers of oncology drug target pipeline